These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10832825)

  • 21. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial.
    Cercek B; Shah PK; Noc M; Zahger D; Zeymer U; Matetzky S; Maurer G; Mahrer P;
    Lancet; 2003 Mar; 361(9360):809-13. PubMed ID: 12642046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of reinfarction subsequent to non-Q-wave infarction.
    Roberts R; Gibson RS
    J Cardiovasc Pharmacol; 1989; 13 Suppl 1():S36-46. PubMed ID: 2468975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group.
    Moss AJ; Oakes D; Rubison M; McDermott M; Carleen E; Eberly S; Brown M
    Am J Cardiol; 1991 Aug; 68(5):429-33. PubMed ID: 1872266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing recurrent myocardial infarction. Use of calcium-channel blockers.
    Roberts R
    Postgrad Med; 1988 Jan; 83(1):249-56. PubMed ID: 3275938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Holter ST monitoring for risk stratification in patients with acute myocardial infarction treated by thrombolysis.
    Stevenson R; Ranjadayalan K; Wilkinson P; Marchant B; Timmis AD
    Br Heart J; 1993 Sep; 70(3):233-40. PubMed ID: 8398493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diltiazem improves left ventricular systolic function following acute myocardial infarction treated with streptokinase. The Calcium Antagonist in Reperfusion Study (CARES) Group.
    Nicolau JC; Ramires JA; Maggioni AP; Garzon SA; Pinto MA; Silva DG; Nogueira PR; Maia LF; Vendramini P; Bassi I
    Am J Cardiol; 1996 Nov; 78(9):1049-52. PubMed ID: 8916489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium antagonists in myocardial infarction.
    Zannad F; Sadoul N
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S16-9. PubMed ID: 1706009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
    Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
    Topol EJ;
    Lancet; 2001 Jun; 357(9272):1905-14. PubMed ID: 11425410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Myocardial infarction beyond the 48 first hours: treatment with calcium channel antagonists].
    Delahaye F; de Gevigney G; Ovize M; Landrivon G; Rabilloud M; André-Fouët X; Delaye J
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1717-24. PubMed ID: 1304145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial.
    Fernandez-Avilés F; Alonso JJ; Castro-Beiras A; Vázquez N; Blanco J; Alonso-Briales J; López-Mesa J; Fernández-Vazquez F; Calvo I; Martínez-Elbal L; San Román JA; Ramos B;
    Lancet; 2004 Sep 18-24; 364(9439):1045-53. PubMed ID: 15380963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised, double-blind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris.
    Göbel EJ; Hautvast RW; van Gilst WH; Spanjaard JN; Hillege HL; DeJongste MJ; Molhoek GP; Lie KI
    Lancet; 1995 Dec 23-30; 346(8991-8992):1653-7. PubMed ID: 8551821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary prevention with calcium antagonists after acute myocardial infarction.
    Hansen JF
    Drugs; 1992; 44 Suppl 1():33-43. PubMed ID: 1283582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low molecular weight heparin for treatment of acute myocardial infarction (FAMI): Fragmin (dalteparin sodium) in acute myocardial infarction.
    Kakkar VV; Iyengar SS; De Lorenzo F; Hargreaves JR; Kadziola ZA;
    Indian Heart J; 2000; 52(5):533-9. PubMed ID: 11256775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial.
    Wallentin L; Wilcox RG; Weaver WD; Emanuelsson H; Goodvin A; Nyström P; Bylock A;
    Lancet; 2003 Sep; 362(9386):789-97. PubMed ID: 13678873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance and beneficial effect of diltiazem on the incidence of early recurrent ischemia after non-Q-wave myocardial infarction: results from the Multicenter Diltiazem Reinfarction Study.
    Gibson RS; Young PM; Boden WE; Schechtman K; Roberts R
    Am J Cardiol; 1987 Aug; 60(4):203-9. PubMed ID: 3303886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of thallium-201 imaging in detecting adverse cardiac events after myocardial infarction and thrombolysis: a follow up of 100 consecutive patients.
    Basu S; Senior R; Dore C; Lahiri A
    BMJ; 1996 Oct; 313(7061):844-8. PubMed ID: 8870569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI Investigators.
    Mueller HS; Forman SA; Menegus MA; Cohen LS; Knatterud GL; Braunwald E
    J Am Coll Cardiol; 1995 Oct; 26(4):900-7. PubMed ID: 7560615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium-channel blockers as adjuvant therapy postthrombolysis.
    Boden WE
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S102-6. PubMed ID: 1724997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.